Cefiderocol Sulfate Tosylate Patent Expiration
Cefiderocol Sulfate Tosylate is Used for treating hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. It was first introduced by Shionogi Inc
Cefiderocol Sulfate Tosylate Patents
Given below is the list of patents protecting Cefiderocol Sulfate Tosylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Fetroja | US10004750 | Salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof | Sep 03, 2035 | Shionogi Inc |
| Fetroja | US9949982 | Preparation containing cephalosporin having a catechol moiety | Sep 03, 2035 | Shionogi Inc |
| Fetroja | US9238657 | Cephalosporin having catechol group | Nov 14, 2033 | Shionogi Inc |
Cefiderocol Sulfate Tosylate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List